Pseudomonas Aeruginosa Small Protease (PASP), a Keratitis Virulence Factor

Overview

Journal Invest Ophthalmol Vis Sci

Specialty Ophthalmology

Date 2013 Apr 4

PMID 23548618

Citations 17

Authors

Aihua Tang

Armando R Caballero

Mary E Marquart

Richard J OCallaghan

Affiliations

Soon will be listed here.

Abstract

Purpose: The virulence contribution of Pseudomonas aeruginosa small protease (PASP) during experimental keratitis was studied by comparing a PASP-deficient mutant with its parent and rescue strains.

Methods: The pasP gene of P. aeruginosa was replaced with the tetracycline resistance gene via allelic exchange. A plasmid carrying the pasP gene was introduced into the PASP-deficient mutant to construct a rescue strain. The PASP protein in the culture supernatants was determined by Western blot analysis. Corneal virulence was evaluated in rabbit and mouse keratitis models by slit lamp examination (SLE), bacterial enumeration, and/or histopathological analysis. Various host proteins and the rabbit tear film were analyzed for their susceptibility to PASP degradation.

Results: The PASP-deficient mutant produced a significantly lower mean SLE score when compared with the parent or rescue strain (P ≤ 0.03) at 29 hours postinfection (PI). All of the strains grew equally in the rabbit cornea (P = 0.971). Corneas infected with the PASP-deficient mutant showed moderate histopathology compared with those infected with the parent or rescue strain, which produced severe pathology inclusive of epithelial erosions, corneal edema, and neutrophil infiltration. In the mouse model, eyes inoculated with the PASP-deficient mutant had a significantly lower mean SLE score at 24 hours PI than the eyes inoculated with the parent or rescue strain (P ≤ 0.007). PASP was found to degrade complement C3, fibrinogen, antimicrobial peptide LL-37, and constituents of the tear film.

Conclusions: PASP is a commonly secreted protease of P. aeruginosa that contributes significantly to the pathogenesis of keratitis.

Citing Articles

and P infectious keratitis: key bacterial mechanisms that mediate pathogenesis and emerging therapeutics.

Shah S, Wozniak R Front Cell Infect Microbiol. 2023; 13:1250257.

PMID: 37671149 PMC: 10475732. DOI: 10.3389/fcimb.2023.1250257.

and the Complement System: A Review of the Evasion Strategies.

Gonzalez-Alsina A, Mateu-Borras M, Domenech-Sanchez A, Alberti S Microorganisms. 2023; 11(3).

PMID: 36985237 PMC: 10056308. DOI: 10.3390/microorganisms11030664.

Genipin Delays Corneal Stromal Enzymatic Digestion.

Donovan C, Koudouna E, Margo C, Avila M, Espana E Transl Vis Sci Technol. 2021; 10(9):25.

PMID: 34424287 PMC: 8394563. DOI: 10.1167/tvst.10.9.25.

Insights into the phylogeny and transcriptional response of serine proteases in a halotolerant cyanobacterium sp. PCC7418.

Patipong T, Kageyama H, Waditee-Sirisattha R Plant Signal Behav. 2021; 16(9):1913556.

PMID: 34184613 PMC: 8281059. DOI: 10.1080/15592324.2021.1913556.

Keratitis: Protease IV and PASP as Corneal Virulence Mediators.

OCallaghan R, Caballero A, Tang A, Bierdeman M Microorganisms. 2019; 7(9).

PMID: 31443433 PMC: 6780138. DOI: 10.3390/microorganisms7090281.

References

Twining S, Kirschner S, Mahnke L, Frank D . Effect of Pseudomonas aeruginosa elastase, alkaline protease, and exotoxin A on corneal proteinases and proteins. Invest Ophthalmol Vis Sci. 1993; 34(9):2699-712. View

Turner J, Cho Y, Dinh N, Waring A, Lehrer R . Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother. 1998; 42(9):2206-14. PMC: 105778. DOI: 10.1128/AAC.42.9.2206. View

Baumann U, Wu S, Flaherty K, McKay D . Three-dimensional structure of the alkaline protease of Pseudomonas aeruginosa: a two-domain protein with a calcium binding parallel beta roll motif. EMBO J. 1993; 12(9):3357-64. PMC: 413609. DOI: 10.1002/j.1460-2075.1993.tb06009.x. View

Kwon B, Hazlett L . Association of CD4+ T cell-dependent keratitis with genetic susceptibility to Pseudomonas aeruginosa ocular infection. J Immunol. 1998; 159(12):6283-90. View

Thibodeaux B, Caballero A, Marquart M, Tommassen J, OCallaghan R . Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida. Curr Eye Res. 2007; 32(4):373-86. DOI: 10.1080/02713680701244181. View

Giese M, Weissman B . Contact lens associated corneal infections. Where do we go from here?. Clin Exp Optom. 2002; 85(3):141-8. DOI: 10.1111/j.1444-0938.2002.tb03026.x. View

Engel L, Hill J, Moreau J, Green L, Hobden J, OCallaghan R . Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence. Invest Ophthalmol Vis Sci. 1998; 39(3):662-5. View

Engel L, Hobden J, Moreau J, Callegan M, Hill J, OCallaghan R . Pseudomonas deficient in protease IV has significantly reduced corneal virulence. Invest Ophthalmol Vis Sci. 1997; 38(8):1535-42. View

Mah-Sadorra J, Yavuz S, Najjar D, Laibson P, Rapuano C, Cohen E . Trends in contact lens-related corneal ulcers. Cornea. 2004; 24(1):51-8. DOI: 10.1097/01.ico.0000138839.29823.57. View

10.

Green M, Apel A, Stapleton F . Risk factors and causative organisms in microbial keratitis. Cornea. 2008; 27(1):22-7. DOI: 10.1097/ICO.0b013e318156caf2. View

11.

Morihara K, Tsuzuki H, Oka T, Inoue H, Ebata M . PSEUDOMONAS AERUGINOSA ELASTASE. ISOLATION, CRYSTALLIZATION, AND PRELIMINARY CHARACTERIZATION. J Biol Chem. 1965; 240:3295-304. View

12.

Barletta J, Angella G, Balch K, Dimova H, Stern G, Moser M . Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor. Invest Ophthalmol Vis Sci. 1996; 37(1):20-8. View

13.

Engel L, Hill J, Caballero A, Green L, OCallaghan R . Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosa. J Biol Chem. 1998; 273(27):16792-7. DOI: 10.1074/jbc.273.27.16792. View

14.

Lomholt J, Poulsen K, Kilian M . Epidemic population structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors. Infect Immun. 2001; 69(10):6284-95. PMC: 98763. DOI: 10.1128/IAI.69.10.6284-6295.2001. View

15.

Tang A, Marquart M, Fratkin J, McCormick C, Caballero A, Gatlin H . Properties of PASP: a Pseudomonas protease capable of mediating corneal erosions. Invest Ophthalmol Vis Sci. 2009; 50(8):3794-801. PMC: 2874894. DOI: 10.1167/iovs.08-3107. View

16.

Mun J, Tam C, Kowbel D, Hawgood S, Barnett M, Evans D . Clearance of Pseudomonas aeruginosa from a healthy ocular surface involves surfactant protein D and is compromised by bacterial elastase in a murine null-infection model. Infect Immun. 2009; 77(6):2392-8. PMC: 2687330. DOI: 10.1128/IAI.00173-09. View

17.

Gambello M, Iglewski B . Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a transcriptional activator of elastase expression. J Bacteriol. 1991; 173(9):3000-9. PMC: 207884. DOI: 10.1128/jb.173.9.3000-3009.1991. View

18.

Matsumoto K, Shams N, Hanninen L, Kenyon K . Cleavage and activation of corneal matrix metalloproteases by Pseudomonas aeruginosa proteases. Invest Ophthalmol Vis Sci. 1993; 34(6):1945-53. View

19.

Malloy J, Veldhuizen R, Thibodeaux B, OCallaghan R, Wright J . Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions. Am J Physiol Lung Cell Mol Physiol. 2004; 288(2):L409-18. DOI: 10.1152/ajplung.00322.2004. View

20.

Kernacki K, Hobden J, Hazlett L, Fridman R, Berk R . In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection. Invest Ophthalmol Vis Sci. 1995; 36(7):1371-8. View